Company intelligence / Profile preview
Nour Heart
Salt Lake City, Utah, United Statesnourheart.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
Nour Heart is a clinical-stage biotechnology company focused on the development of regenerative cell therapies for the treatment of heart failure and other cardiovascular conditions. The company's core technology, the NourCell platform, involves the use of autologous stem cells delivered via a proprietary retrograde coronary sinus infusion method to repair damaged myocardium. This approach aims to restore cardiac function and improve patient outcomes without the need for highly invasive surgical procedures. Nour Heart is currently advancing its lead programs through clinical trials, targeting both ischemic and non-ischemic heart failure populations.
- Therapeutic areas
- Cardiovascular
- Modalities
- Cell therapyStem cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Nour Heart.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nour Heart.